LRRK2 Expression in Normal and Pathologic Human Brain and in Human Cell Lines
Open Access
- 1 October 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 65 (10), 953-963
- https://doi.org/10.1097/01.jnen.0000235121.98052.54
Abstract
Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been recently identified in families with autosomal-dominant late-onset Parkinson disKeywords
This publication has 28 references indexed in Scilit:
- LRRK2 expression linked to dopamine‐innervated areasAnnals of Neurology, 2006
- LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brainEuropean Journal of Neuroscience, 2006
- Biochemical and pathological characterization of Lrrk2Annals of Neurology, 2006
- The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activityHuman Molecular Genetics, 2005
- LRRK2 Haplotype Analyses in European and North African Families with Parkinson Disease: A Common Founder for the G2019S Mutation Dating from the 13th CenturyAmerican Journal of Human Genetics, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Induction of complement C9 messenger RNAs in human neuronal cells by inflammatory stimuli: relevance to neurodegenerative disordersExperimental Gerontology, 2001
- Genetics of Parkinsonism: a reviewAnnals of Human Genetics, 2001
- A susceptibility locus for Parkinson's disease maps to chromosome 2p13Nature Genetics, 1998
- Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiationCell Differentiation, 1984